Senior Accountant
Full-timeSeniorCapricor TherapeuticsRare Diseases
$85K - $95K/yr(from employer)
Description
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
We are seeking a detail-oriented and highly motivated Senior Accountant to join our growing finance team. This role will play a key part in supporting core accounting functions, including general ledger management, fixed assets, prepaids, and construction-in-progress (CIP). The ideal candidate is a collaborative team player who thrives in a dynamic, fast-paced environment and is eager to contribute to a meaningful mission.
Capricor Therapeutics
BIOTECHNOLOGY
Cell and exosome-based therapies for rare diseases
LocationSAN DIEGO, CA
Open Jobs32
Rare Diseases
View Company ProfilePipeline
CAP-1002 Allogeneic Cardiosphere-Derived CellsN/A
Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of FamiliesN/A
Allogeneic Cardiosphere-Derived CellsPhase 1
CAP-1002 Allogeneic Cardiosphere-Derived CellsPhase 1/2
CenderitidePhase 1/2